RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Hologic Stock

Hologic Revenue 2025

Hologic Revenue

4.25 B USD

Ticker

HOLX

ISIN

US4364401012

WKN

879100

In 2025, Hologic's sales reached 4.25 B USD, a 5.45% difference from the 4.03 B USD sales recorded in the previous year.

The Hologic Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2030e5.5141,16
2029e5.1144,38
2028e4.9845,49
2027e4.7647,65
2026e4.4950,47
2025e4.2553,34
20244.0356,25
20234.0355,85
20224.8662,00
20215.6367,39
20203.7859,67
20193.3751,96
20183.2252,73
20173.0652,99
20162.8355,19
20152.7152,96
20142.5350,27
20132.4946,67
2012249,66
20111.7951,60
20101.6843,86
20091.6452,38
20081.6753,30
20070.7446,76
20060.4641,78
20050.2938,89

Hologic Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Hologic, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Hologic from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Hologic’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Hologic. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Hologic’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Hologic’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Hologic’s growth potential.

Hologic Revenue, EBIT and net profit per share

DateHologic RevenueHologic EBITHologic Net Income
2030e5.51 B undefined0 undefined0 undefined
2029e5.11 B undefined1.73 B undefined1.23 B undefined
2028e4.98 B undefined1.63 B undefined1.24 B undefined
2027e4.76 B undefined1.47 B undefined1.2 B undefined
2026e4.49 B undefined1.39 B undefined1.09 B undefined
2025e4.25 B undefined1.29 B undefined985.93 M undefined
20244.03 B undefined970.2 M undefined789.5 M undefined
20234.03 B undefined941 M undefined456 M undefined
20224.86 B undefined1.65 B undefined1.3 B undefined
20215.63 B undefined2.48 B undefined1.87 B undefined
20203.78 B undefined1.15 B undefined1.12 B undefined
20193.37 B undefined568.2 M undefined-203.6 M undefined
20183.22 B undefined508 M undefined-111.3 M undefined
20173.06 B undefined483.8 M undefined755.5 M undefined
20162.83 B undefined559.1 M undefined330.8 M undefined
20152.71 B undefined483.6 M undefined131.6 M undefined
20142.53 B undefined363.6 M undefined17.3 M undefined
20132.49 B undefined203.1 M undefined-1.17 B undefined
20122 B undefined163.1 M undefined-73.6 M undefined
20111.79 B undefined281.9 M undefined157.2 M undefined
20101.68 B undefined181.7 M undefined-62.8 M undefined
20091.64 B undefined324.1 M undefined-2.22 B undefined
20081.67 B undefined377 M undefined-415.6 M undefined
2007738.4 M undefined147.8 M undefined94.6 M undefined
2006462.7 M undefined65.1 M undefined27.4 M undefined
2005287.7 M undefined32.6 M undefined28.3 M undefined

Hologic stock margins

The Hologic margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Hologic. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Hologic.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Hologic's sales revenue. A higher gross margin percentage indicates that the Hologic retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Hologic's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Hologic's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Hologic's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Hologic. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Hologic's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Hologic Margin History

Hologic Gross marginHologic Profit marginHologic EBIT marginHologic Profit margin
2030e56.25 %0 %0 %
2029e56.25 %33.79 %24.09 %
2028e56.25 %32.79 %24.93 %
2027e56.25 %30.83 %25.28 %
2026e56.25 %30.83 %24.18 %
2025e56.25 %30.33 %23.2 %
202456.25 %24.07 %19.59 %
202355.85 %23.35 %11.31 %
202262 %33.89 %26.77 %
202167.39 %44.08 %33.23 %
202059.67 %30.47 %29.53 %
201951.96 %16.87 %-6.05 %
201852.73 %15.79 %-3.46 %
201752.99 %15.82 %24.7 %
201655.19 %19.74 %11.68 %
201552.96 %17.88 %4.87 %
201450.27 %14.37 %0.68 %
201346.67 %8.15 %-47.06 %
201249.66 %8.14 %-3.68 %
201151.6 %15.75 %8.79 %
201043.86 %10.82 %-3.74 %
200952.38 %19.8 %-135.4 %
200853.3 %22.51 %-24.82 %
200746.76 %20.02 %12.81 %
200641.78 %14.07 %5.92 %
200538.89 %11.33 %9.84 %

Hologic Aktienanalyse

What does Hologic do?

Hologic Inc. is a company from the United States that has established itself in the medical technology market. The company was founded in 1985 by Jay A. Stein, who set the goal of developing products and services that contribute to improving people's lives. Hologic specializes in artificial intelligence (AI) based diagnostic and therapeutic technology that increases the safety, effectiveness, and accuracy of medical procedures. The company initially focused on products in the field of mammography, but has since expanded to various sectors including imaging, gynecology, skeletal, and surgery. Hologic offers its customers products such as tomosynthesis systems, robot-assisted surgery systems, image analysis software, and a variety of reagents, kits, and tests. The company's business model is focused on innovative technology and science, aiming to optimize medical interventions and thus reduce and improve healthcare costs. Hologic is dedicated to research and development and has already filed dozens of patents. In the field of breast cancer diagnostics, Hologic has developed various mammography systems that have broken the standard of mammography. Through the use of tomosynthesis, a 3D-based diagnostic, it is possible to detect tumors and malignant changes earlier. This procedure has been widely used by many doctors around the world and has proven to be a reliable method for early detection of breast cancer. In gynecology, Hologic specializes in the development of diagnostic tests for infectious agents and hormones. The tests, such as the Aptima HPV test, are fast, sensitive, and reliable. They help to detect infectious agents earlier and initiate appropriate therapy. Hologic Taurus, a robot-assisted surgery system, has been developed to enable minimally invasive interventions that can be used to treat uterine fibroids. This method allows for a drastic reduction in hospital stay duration and recovery time. In the field of skeletal, Hologic offers various systems that are helpful in the diagnosis and treatment of osteoporosis. The widely used DXA system (Dual-Energy X-Ray Absorptiometer) is still one of the most accurate devices for measuring bone density. Additionally, Hologic is an company that not only focuses on medical technology but also pursues the larger goal of improving people's lives. An example of this is their partnership with the organization Pink Ribbon, which serves as a global ambassador for breast cancer early detection. Hologic has developed a special mammography system called Pink Affirm. For every system sold, Hologic donates a certain amount to Pink Ribbon. Overall, Hologic Inc. has become an important player in the field of medical technology and diagnostics. Through its innovative technologies and products, the company contributes to improving the health and lives of people worldwide. Hologic ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Hologic revenue by segment

  • 55 % Diagnostics

  • 31 % Breast Health

  • 10 % GYN Surgical

  • 2 % Skeletal Health

  • 2 % Medical Aesthetics

Revenue Details

Understanding Hologic's Sales Figures

The sales figures of Hologic originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Hologic’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Hologic's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Hologic’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Hologic stock

How much revenue did Hologic generate this year?

Hologic has achieved a revenue of 4.25 B USD this year.

How much was the turnover of the company Hologic compared to the previous year?

The revenue of Hologic has increased by 5.45% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Hologic?

The revenue of Hologic is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Hologic measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Hologic so important for investors?

The revenue of Hologic is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Hologic pay?

Over the past 12 months, Hologic paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Hologic is expected to pay a dividend of 0 USD.

What is the dividend yield of Hologic?

The current dividend yield of Hologic is .

When does Hologic pay dividends?

Hologic pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Hologic?

Hologic paid dividends every year for the past 0 years.

What is the dividend of Hologic?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Hologic located?

Hologic is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hologic kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hologic from 1/22/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/22/2025.

When did Hologic pay the last dividend?

The last dividend was paid out on 1/22/2025.

What was the dividend of Hologic in the year 2024?

In the year 2024, Hologic distributed 0 USD as dividends.

In which currency does Hologic pay out the dividend?

The dividends of Hologic are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Hologic stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Hologic

Our stock analysis for Hologic Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hologic Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.